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We demonstrate that, in rat pituitary, pptidylglycine a-amidating enzyme was encoded by at least 5 distinct mRNAs. Southern blot and ribo- 
nuclease protection analyses revealed that the mRNAs arose through alternative splicing. A variant lacking the transmembrane domain-coding 
sequence was a major mRNA species for the enzyme in the pituitary. When the cDNAs were expressed in COS-7 cells, the variant was the most 
efficient in producing a secretory form (37 LDA) of the enzyme. 
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1. INTRODUCTION 
Peptide cu-amidation represents an important step in 
the maturation of a large number of endocrine and 
neuronal peptides, and other biologically active pep- 
tides [l]. The enzyme responsible for this post- 
translational modification is known as peptide cy- 
amidating enzyme (peptidylglycine cu-amidating 
monooxygenase; EC 1.14.17.3), and was first identified 
in porcine pituitary [2]. Peptide cr-amidating enzymes 
purified from various sources display a substantial 
heterogeneity in apparent molecular weights, ranging 
from 37 kDa to 75 kDa [3,4]. The distribution of the (Y- 
amidating activity in soluble and membrane fractions 
also varies among tissues [S ,6]. These observations ug- 
gest the existence of a certain molecular diversity in the 
cu-amidating enzyme. In the present study, we have 
identified five splice variants of a-amidating enzyme 
mRNA from rat pituitary and expressed them in COS-7 
cells. 
2. EXPERIMENTAL 
2.1. cDNA cloning and sequencing 
Using 5 peg of poly(A)+RNA isolated from pituitaries of adult 
Wistar rats, cDNA libraries were constructed as described [7]. A 
cDNA library (4.8 x ld independent clones) was screened with a syn- 
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thetic I&base complement of the bovine a-amidating enzyme cDNA 
(base numbers 389-468 in [8]), yielding one positive clone. As the 
cDNA insert of the clone lacked a coding sequence corresponding to 
the COOH-terminal two-thirds of the bovine acamidating enzyme [8], 
the amplified cDNA library (3 x 106 clones) and another cDNA 
library (2.2 x ld clones) were rescreened with the 5’ portion (285 bp) 
of the cDNA insert as probe. Cloned cDNAs were subcloned into PBS 
vectors (Stratagene) and sequenced by the dideoxy chain termination 
method [9]. 
2.2. Southern blot analysis of genomic DNA 
High molecular weight DNA was prepared from rat liver, digested 
with various restriction enzymes, electrophoresed on 0.8% agarose 
gel and then blotted onto a nitrocellulose filter [7]. The filter was 
hybridized using “P-labeled EcoRI-EcoRV fragment (172 bp) of 
cDNA clone 202 (see Fig. 1) as probe [7]. 
2.3. RNase protection analysis 
EcoRI(-1)-Nsrl (700) fragment of clone 205 and SphI(1872)-Xmal 
(2948) fragment of clone 202 (see Fig. 1) were subcloned into PBS vec- 
tor, and “P-labeled antisense RNAs were synthesized in vitro [lo]. 
The “P-labeled RNA probe (1 x 106 cpm) was hybridized with 40 Fcg 
of rat pituitary total RNA or 10 pg of rat atrium total RNA, and 
treated with RNase A and RNase Ti as described (111. The protected 
fragments were electrophoresed in 8% polyacrylamide/urea gels 
followed by autoradiography. 
2.4. Construction of expression plasmids 
The 2.58 kbp EcoRI-Xmal fragment of the cy-amidating enzyme 
cDNA clone 205 (see Fig. 1) was subcloned into the HindIII/Bggl site 
of the pSV2 vector [12] using synthetic oligonucleotide linkers. The 
resulting plasmid. designated as SV-205, carries the entire coding se- 
quence of the a-amidating enzyme cDNA (clone 205) downstream of 
the simian virus 40 early promotor. Expression plasmids SV-201, 
-202, -203 and -204 were constructed by replacement of NsI (700)- 
Xmal fragment of SV-205 with NsiI (700)- Xmal fragments of cDNA 
clones 201, 202, 203 and 204 respectively: this was based on the fin- 
ding that the 5’ coding sequences upstream of NsiI site (700) were 
identical in each mRNA (see Figs. 1 and 3B). Thus, expression 
plasmids SV-201, -202, -203. -204 and -205 had unique open reading 
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frames corresponding to cDNA clones 201, 202, 203, 204 and 205, 
respectively. 
2.5. DNA transfection 
COS-7 cells were transfected [13] with 20 /rg of each expression 
plasmid per 5 x ld cells. pSV2 vector with no insert was used as con- 
trol. After incubation for 24 h at 35°C under 3% COz, cells were 
washed twice with 10 ml of Dulbecco’s modified Eagle’s medium 
(DMEM) supplemented with 0.2% bovine serum albumin (BSA) and 
then incubated for 48 h in 10 ml of DMEM/O.Z% BSA at 37°C under 
5% coz. 
2.6. Assay of expressed a-amidating enzyme 
After the 48 h transient expression, conditioned media were remov- 
ed, and cells were washed and scraped gently with a rubber policeman 
in the presence of phosphate-buffered saline. After centrifugation at 
low speed for 4 min, cell pellets were weighed and homogenized in 9 
volumes of 0.25 M sucrose containing 10 mM mannitol, 50 mM 
Hepes-KOH (pH 7.0) and 300 /cg/ml phenylmethyl-sulfonylfluoride 
at 4°C using a teflon-glass homogenizer. Soluble and membrane frac- 
tions were prepared according to the method of May et al. [5] with 
some modifications. Homogenate was centrifuged at 6OOxg for 10 
min. Supernatants were subjected to three cycles of freezing and 
thawing, followed by sonication for 1 min, and centrifuged at 
100 OOOxg for 60 min at 4°C. The supernatants from the high speed 
centrifugation were assayed for the soluble enzyme activity. The 
pellets were once washed with the homogenizing buffer containing 
0.15 M KCl, resuspended in the homogenizing buffer containing 1% 
Triton X-100 and shaken for 30 min at 4’C. After centrifugation at 
100 000 x g for 60 min at 4°C the resultant supernatants were assayed 
for the membrane-bound enzyme activity. Amidation assay was per- 
formed as described [14] in 120~1 of 50 mM Hepes-KOH, pH 8.5, us- 
ing 40 picomoles of %D-Tyr-Val-Gly as substrate. 
3. RESULTS 
3.1. Isolation and characterization of cDNAs en- 
coding pituitary peptide cu-amidating enzyme 
Five cDNA clones isolated differed from each other 
by the presence or absence of 315bp, 204-bp and 54-bp 
regions designated as region A, region B and region C, 
respectively (Fig. 1). clones 201 had no deleted seg- 
ments. Clone 202 lacked region A, clone 203 region B 
and clone 204 region C. Clone 205 lacked both regions 
A and C. Deletions/insertions of these regions did not 
cause any translational frameshift. There were no base 
substitutions or deletions in the overlapping sequences 
of the 5 cDNAs. Sequencing analysis revealed that only 
clone 205 included the initiator Met as compared with 
the deduced amino acid sequence of bovine pituitary cy- 
amidating enzyme [8]. The cDNA coded for 853 amino 
acid residues which terminated at position 2560 
(Fig. 2). The NHz-terminal sequence (residues l-25) 
had the characteristics of a signal peptide with a consen- 
sus cleavage site [IS]. The hydropathicity profile 
analysis indicated a clear hydrophobic segment con- 
sisting of 24 uncharged amino acid residues (residues 
762-785) in the COOH-terminal portion of the protein 
(data not shown). This segment is contained in region B 
and is therefore missing in clone 203 (see Fig. 1). 
3.2. Southern blot and RNase protection analyses 
Only one band was recognized in each digestion of 
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Fig. 1. Schematic representation of cDNA clones coding for peptide 
cY-amidating enzymes. Nucleotide numbers are given at the top, and 
sites for restriction enzymes, B (BarnHI), N (Nsl), RI (EcoRI), RV 
(EcoRV), S (SphI), and X (XmaI) are demarcated by vertical bars 
(EcoRI sites are derived from EcoRI linkers). Nucleotide residues are 
numbered in the 5’ to 3 ’ direction, beginning with the first residue of 
the ATG triplet encoding the initiator methionine. Nucleotides on the 
5 ’ side of residue 1 are indicated by negative numbers. The predicted 
protein product is shown below the restriction map. SIG, signal se- 
quence. TM, transmembrane domain. PK (Pro-Lys), KK (Lys-Lys) 
and RK (Arg-Lys) are predicted endoproteolytic cleavage sites. 
Regions A, B and C are alternatively spliced regions. Horizontal bars 
indicate 3’untranslated regions and poly(A) tracts. Clone 201 con- 
tained extraneous 130 bp at the 5’ end (cross-hatched area) which has 
been found to be a cloning artefact (data not shown). 
genomic DNA (Fig. 3A). An antisense RNA probe cor- 
responding to EcoRI(-I)-NsiI (700) fragment of clone 
205 yielded a single protected fragment of 700 bases in 
both pituitary and atrium (Fig. 3B). On the other hand, 
several fragments were protected with SphI (1872)- 
XmaI (2948) fragment of clone 202 corresponding to 
the COOH-terminus of the enzyme. Protections of 
1076-, 826-, 622-, 250- and 196-base fragments are ex- 
actly what would be predicted to result from the 
presence of mRNAs corresponding to cDNA clones 
201-205 (Fig. 1). A densitometric analysis indicated 
that the 622- and 250-base fragments, corresponding to 
clone 203, are the major protected fragments in the 
pituitary, whereas in the atrium it is the 1076-base frag- 
ment, corresponding to clones 201 and 202, that is most 
abundant. 
3.3. Expression of a-amidating enzyme cDNAs in 
COS- 7 ceils 
Soluble fractions, membrane fractions and condi- 
tioned media of COS-7 cells transfected with expression 
,lasmids carrying cu-amidating enzyme cDNAs ex- 
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Fig. 2. cDNA sequence of clone 205 and deduced amino acid sequence. Region A is inserted at position A ( 
B missing in clone 203 is hatched and overlined. Region C is inserted at position C (1) zx 
) in clones 201,203 and 204. Region 
in clones 201, 20 and 203. Amino acids are numbered 
below the sequence. The putative polyadenylation signal and predicted endoproteolytic leavage sites are underlined. 
hibited higher cr-amidating activities than those of con- 
trol cells (Table I). Cells transfected with W-203, which 
lacks the COOH-terminal hydrophobic sequence, 
released a very much higher cY-amidating activity into 
the culture medium than other transfectants. a- 
Amidating activity secreted from this transfectant was 
recovered as a single peak at approximately 37 kDa 
upon gel filtration (data not shown). 
4. DISCUSSION 
In the present study, we have identified 5 a-ami- 
dating enzyme cDNA species in rat pituitary cDNA 
libraries. As Southern blot analysis indicated that the 
enzyme gene is a single copy in the rat genome, the 
diversity of the mRNAs is thought to be due to alter- 
native splicing. RNase protection assay suggested that 
tissue-specific alternative splicing events occur in the 3 ’ 
region of the mRNA and that the species lacking the 
COOH-terminal hydrophobic segment is a major form 
of cY-amidating enzyme mRNAs in the pituitary. The 
enzyme cDNAs, which have so far been isolated from 
bovine pituitary [8] and from rat atrium [16], corre- 
sponded to clones 201, 202 and 204. 
COS-7 cells transfected with the expression plasmids, 
SV-201, -202, -204 and -205, which contained the 
COOH-terminal hydrophobic segment, exhibited 
significantly higher cu-amidating activities in the mem- 
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Fig, 3. (A) Southern blot analysis of genomic DNA. Tenpg of rat liver DNA was digested with BumHI, DraI, EcoRI, EcoRV, HindIII, N.rI. Posi- 
tions of size markers are given at the left. (B) RNase protection analysis. Atrium RNA (lanes 1 and J) and pituitary RNA (lanes 2 and 4) were 
hybridized with “P-labeled antisense RNA probe 1 (lanes 1 and 2) and with probe 2 (lanes 3 and 4). Positions of size markers are given at the center. 
Arrows indicate protected fragments. A diagram of probes 1 and 2 and of the expected protected fragments is shown in Fig. 1. 
brane fractions. On the other hand, cells transfected 
with SV-203, which lacked the COOH-terminal hydro- 
phobic segment, released a very much higher (Y- 
amidating activity into culture media than other trans- 
fectants and exhibited a lower activity in the membrane 
fraction. These results indicate that the COOH- 
terminal hydrophobic segment is a transmembrane do- 
main and actually serves as a membrane anchor. Thus 
it is reasonable to assume that the enzyme protein lack- 
ing the transmembrane domain is primarily soluble and 
is most efficiently secreted as a 37 kDa protein, which 
may have resulted from the NHz-terminal region of the 
precursor by a monobasic cleavage [l] at Pro-382- 
Table I 
cu-Amidating activity in transfected COS-7 cells 
Plasmid cu-Amidating activity (fmo1/h/106 cells) 
Membrane- Soluble Conditioned 
bound medium 
sv-201 392 1318 46800 
sv-202 365 1230 38700 
SV-203 90 327 214100 
sv-204 410 1138 39700 
sv-205 397 1273 47300 
psv2 42 162 7400 
The activity is expressed as fmol of D-Tyr-Val-Gly converted into D- 
Tyr-Val-NHr per h per ld cells. Similar results were obtained in 3 dif- 
ferent experiments. 
Lys-383 (see Fig. 1). The enzyme proteins encoded by 
clones 201, 202, 204 and 205 may be initially synthesiz- 
ed as membrane-bound forms, which are subsequently 
converted into soluble forms and secreted. 
Substantial levels of peptide cY-amidating activity 
have been detected in serum [ 17,181 and in cerebro- 
spinal fluid [19]. The mRNA species lacking a trans- 
membrane domain-coding sequence characterized in 
the present study may in a large part account for the ex- 
tracellular nature of the distribution of the enzyme. 
There is a practical interest in the present results, 
since it should be possible, by using the cDNA for the 
secretory form of peptide cY-amidating enzyme built in- 
to expression vectors, to drive cell lines and yeast or 
prokaryotic cells so as to undertake large-scale synthesis 
of the enzyme. 
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